Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

TransMedics Group, Inc.

NASDAQ: TMDX · Industrial Applications and Services · 4 alerts · CIK 1756262

Share price
$92.21Close, Nov 16
Market cap
$3.2B
Shares outstanding
34.73MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Electromedical & Electrotherapeutic ApparatusSIC 3845

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All TransMedics Group, Inc. filings on SEC EDGAR ↗

4:13 PM ET 10-Q
Financial Results

TransMedics Group Q3 2026 Results: Net Income $17.1M, Down 29.8% YoY

TransMedics Group reported total revenue of $203.0 million for the third quarter of 2026, a 41% increase year-over-year, driven by growth in both product and service revenue. Net income for the quarter was $17.1 million, down from $24.3 million in the prior year period, primarily due to increased operating expenses in research, development, and clinical trials.

Key figure
Net income $17.1M · -29.8% YoY
4:03 PM ET 8-K
Financial Results

TransMedics Group Financial Results

TransMedics reported record third-quarter 2026 revenue of $203.0 million, a 41% increase year-over-year, driven by strong growth in both product and service revenue. The company achieved net income of $17.1 million and raised its full-year 2026 revenue guidance to a range of $764 million to $774 million.

“The third quarter of 2026 was the strongest in TransMedics’ history, with record revenue and record case volume. Importantly, we delivered these results despite typical third quarter seasonality and before any contribution from ENHANCE Part B or DENOVO.”

Waleed Hassanein, MD, President and Chief Executive Officer

“We enter 2027 with strong momentum and a robust set of growth catalysts. ENHANCE Heart Part B and DENOVO Lung target large, untapped heart and lung segments, with two shots on goal in each through OCS and CHOPS.”

Waleed Hassanein, MD, President and Chief Executive Officer

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.